Showing results (71-80 of 234) with videos related to

Sort By:
Pageof 24
Leukemia Research|April 1, 2014
IL2/IL-4, OX40L and FDC-like cell line support the in vitro tumor cell growth of adult T-cell leukemia/lymphomaDai Chihara, Yoshitoyo Kagami, Harumi Kato, et al.
Cancer Research|May 19, 2006
Silencing of bidirectional promoters by DNA methylation in tumorigenesisJingmin Shu, Jaroslav Jelinek, Hao Chang, et al.
Cancer Treatment and Research Communications|November 14, 2020
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib studyMichael Schaffer, Shalini Chaturvedi, Cuc Davis, et al.
Human Pathology|January 21, 2014
Indolent peripheral T-cell lymphoma involving the gastrointestinal tractVasiliki Leventaki, John T Manning, Rajayalakshmi Luthra, et al.
Blood|June 20, 2023
Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphomaDai Chihara, Laura Liao, Joseph Tkacz, et al.
British Journal of Haematology|December 17, 2016
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphomaDai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
Cancer Science|November 10, 2007
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaYasuhiro Oki, Michinori Ogura, Harumi Kato, et al.
Neuro-Oncology|October 22, 2015
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphomaChan Yoon Cheah, Sarah Milgrom, Dai Chihara, et al.
European Journal of Haematology|December 6, 2012
Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myelomaKan-Ichi Iwama, Dai Chihara, Kenji Tsuda, et al.
Blood Advances|January 25, 2023
Outcomes of breakthrough COVID-19 infections in patients with hematologic malignanciesKelly S Chien, Christine B Peterson, Elliana Young, et al.
Pageof 24